Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies

INTRODUCTION: The introduction of tau imaging agents such as (18)F-THK523 offers new hope for the in vivo assessment of tau deposition in tauopathies such as Alzheimer’s disease (AD), where preliminary (18)F-THK523-PET studies have demonstrated significantly higher cortical retention of (18)F-THK523...

Descripción completa

Detalles Bibliográficos
Autores principales: Fodero-Tavoletti, Michelle T, Furumoto, Shozo, Taylor, Leanne, McLean, Catriona A, Mulligan, Rachel S, Birchall, Ian, Harada, Ryuichi, Masters, Colin L, Yanai, Kazuhiko, Kudo, Yukitsuka, Rowe, Christopher C, Okamura, Nobuyuki, Villemagne, Victor L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979096/
https://www.ncbi.nlm.nih.gov/pubmed/24572336
http://dx.doi.org/10.1186/alzrt240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979096/
https://www.ncbi.nlm.nih.gov/pubmed/24572336
http://dx.doi.org/10.1186/alzrt240

Ejemplares similares